Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30152% above fair value
$319.09−3.85 (-1.19%)
Close on Nov 13, 2026Market cap $46.00BP/E –Yield –
Natera operating margin
Operating margin is operating income as a percentage of revenue.
Natera's operating margin for the twelve months ending Sep 30, 2026 was -9.0%. For fiscal 2025 it was -13.4%, against -13.1% the year before. The highest annual figure on record is 0.4% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -13.4% | −0.3 |
| FY2024 | Dec 31, 2024 | -13.1% | +28.1 |
| FY2023 | Dec 31, 2023 | -41.2% | +24.7 |
| FY2022 | Dec 31, 2022 | -66.0% | +8.9 |
| FY2021 | Dec 31, 2021 | -74.8% | −19.5 |
| FY2020 | Dec 31, 2020 | -55.3% | −16.8 |
| FY2019 | Dec 31, 2019 | -38.5% | +6.0 |
| FY2018 | Dec 31, 2018 | -44.5% | +20.1 |
| FY2017 | Dec 31, 2017 | -64.6% | −17.0 |
| FY2016 | Dec 31, 2016 | -47.6% | −16.1 |
| FY2015 | Dec 31, 2015 | -31.4% | −31.9 |
| FY2014 | Dec 31, 2014 | 0.4% | +46.2 |
| FY2013 | Dec 31, 2013 | -45.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -8.6% | +7.9 |
| Q2 FY2026 | Jun 30, 2026 | -10.1% | +10.1 |
| Q1 FY2026 | Mar 31, 2026 | -13.4% | +2.4 |
| Q4 FY2025 | Dec 31, 2025 | -3.4% | +10.2 |
| Q3 FY2025 | Sep 30, 2025 | -16.5% | −7.5 |
| Q2 FY2025 | Jun 30, 2025 | -20.2% | −9.6 |
| Q1 FY2025 | Mar 31, 2025 | -15.8% | +4.4 |
| Q4 FY2024 | Dec 31, 2024 | -13.6% | +13.6 |
| Q3 FY2024 | Sep 30, 2024 | -8.9% | +32.4 |
| Q2 FY2024 | Jun 30, 2024 | -10.6% | +32.4 |
| Q1 FY2024 | Mar 31, 2024 | -20.2% | +37.0 |
| Q4 FY2023 | Dec 31, 2023 | -27.2% | +38.1 |
| Q3 FY2023 | Sep 30, 2023 | -41.4% | +15.2 |
| Q2 FY2023 | Jun 30, 2023 | -43.0% | +29.2 |
| Q1 FY2023 | Mar 31, 2023 | -57.2% | +13.4 |
| Q4 FY2022 | Dec 31, 2022 | -65.3% | +15.5 |
| Q3 FY2022 | Sep 30, 2022 | -56.5% | +38.5 |
| Q2 FY2022 | Jun 30, 2022 | -72.2% | +9.0 |
| Q1 FY2022 | Mar 31, 2022 | -70.6% | −29.3 |
| Q4 FY2021 | Dec 31, 2021 | -80.7% | −14.9 |
| Q3 FY2021 | Sep 30, 2021 | -95.0% | −38.2 |
| Q2 FY2021 | Jun 30, 2021 | -81.2% | −21.4 |
| Q1 FY2021 | Mar 31, 2021 | -41.4% | −4.3 |
| Q4 FY2020 | Dec 31, 2020 | -65.8% | −24.0 |
| Q3 FY2020 | Sep 30, 2020 | -56.8% | −29.8 |
| Q2 FY2020 | Jun 30, 2020 | -59.7% | −21.2 |
| Q1 FY2020 | Mar 31, 2020 | -37.1% | +10.4 |
| Q4 FY2019 | Dec 31, 2019 | -41.8% | +2.6 |
| Q3 FY2019 | Sep 30, 2019 | -27.1% | +14.5 |
| Q2 FY2019 | Jun 30, 2019 | -38.5% | +4.6 |
| Q1 FY2019 | Mar 31, 2019 | -47.5% | +1.4 |
| Q4 FY2018 | Dec 31, 2018 | -44.4% | +45.2 |
| Q3 FY2018 | Sep 30, 2018 | -41.6% | +4.5 |
| Q2 FY2018 | Jun 30, 2018 | -43.2% | +11.1 |
| Q1 FY2018 | Mar 31, 2018 | -49.0% | +21.0 |
| Q4 FY2017 | Dec 31, 2017 | -89.6% | −3.8 |
| Q3 FY2017 | Sep 30, 2017 | -46.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -54.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -70.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -85.8% | – |
See a number that looks wrong?